References list

• Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses.
  Bai, Bingke, et al. Mol. Immunol. 2008 Feb;45: 868-75
• Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
  Cao, Lei, et al. Mol Med Rep 2015 Aug;12: 2473-80
• Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch.
  Chen, Chia-Hung, et al. Int J Nanomedicine 2012;7: 607-21
• Removing N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine.
  Ge, Guohong, et al. PLoS ONE 2012;7: e41573
• Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
  Hu, Hui, et al. Clin. Vaccine Immunol. 2007 Jul;14: 894-901
• Characterization of the immune responses elicited by baculovirus-based vector vaccines against influenza virus hemagglutinin.
  Hu, Zhi-peng, et al. Acta Pharmacol. Sin. 2012 Jun;33: 783-90
• Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice.
  Xie, Lilan, et al. Vaccine 2019 May 31;37: 3335-3342
• Administration with Vaccinia Virus Encoding Canine Parvovirus 2Elicits Systemic Immune Responses in Mice and Dogs.
  Zhao, Wanbo, et al. Viral Immunol. 2020 Jul/Aug;33 (6): 434-443
• A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.
  Zheng, Liyun, et al. BMC Infect. Dis. 2009 Feb 12;9: 17